Picking up on scalability, I would expect new sites to be opening in Sydney, Brisbane and Perth once the Melbourne site is bedded down and we have a better handle on profitability and cashflow.
Then who knows what might happen….especially if the FDA follows Australia’s lead and allows this type of treatment going forward.
sad to see the SP where it is but the underlying business feels like it is heading in the right direction.
